Literature DB >> 9182246

Cardiac alpha(1)-adrenoceptors that regulate contractile function: subtypes and subcellular signal transduction mechanisms.

M Endoh1.   

Abstract

Activation of alpha(1)-adrenoceptors as well as endothelin (ET) and angiotensin II (Ang II) receptors in cardiac muscle is coupled to acceleration of the hydrolysis of phosphoinositide (PI), with resultant production of inositol 1,4,5-trisphosphate (IP(3)) and diacylglycerol. There is an excellent correlation between the extent of acceleration of the PI hydrolysis and the positive inotropic effect (PIE) under most experimental conditions after the administration of a-adrenoceptor agonists, ET and Ang II in the rabbit ventricular muscle. The PIE of the alpha-adrenoceptor agonists, ET and Ang II is associated with a negative lusitropic effect and an increase in the sensitivity of myofilaments to Ca(2)+ ions. The PIE can be selectively inhibited by inhibitors of protein kinase C (PKC) such as staurosporine, NA 0345 and H-7, with little effect on the PI hydrolysis and the PIE of isoproterenol and Bay k 8644. Surprisingly, an activator of PKC, phorbol 12,13-dibutyrate (PDBu), selectively and more completely inhibited the PIE and acceleration of PI hydrolysis induced by the alpha-adrenoceptor agonists as well as by ET and Ang II in the rabbit. These receptor agonists consistently cause intracellular alkalinization by activation of Na+-H+ exchange, while the effects on membrane ion channel activities are divergent. For example, alpha-adrenoceptor agonists cause monophasic prolongation of the action potential, the time course of which coincides well with that of the PIE, while ET and Ang II produce a biphasic change in action potential duration, i.e., the long-lasting prolongation preceded by a transient abbreviation. Alpha-adrenoceptor agonists scarcely affect I(ca), whereas ET elicits a biphasic alteration of the current. In addition, the potassium current, I(K1), is markedly suppressed by alpha-adrenoceptor agonists, but this effect is not revealed with Ang II under the same experimental condition. These results indicate that the effects of alpha(1)-adrenoceptor stimulation are partially shared by those of FT and Ang II receptor activation in the heart. Approximately 60% of the total population of alpha(1)-adrenoceptors in the rabbit ventricle are composed of alpha(1A) subtype, which is susceptible to chlorethylclonidine (CEC) and is predominantly responsible for the alpha(1)-mediated PIE and PI hydrolysis. The remaining fraction that belongs to alpha(1A) subtype is further subclassified into the WB 4101-sensitive (partly coupled to PI hydrolysis) and the niguldipine-sensitive (PI hydrolysis-unrelated) subtypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9182246     DOI: 10.1007/BF02529138

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  91 in total

1.  Mechanisms for the positive inotropic effect of alpha 1-adrenoceptor stimulation in rat cardiac myocytes.

Authors:  D Fedida; R A Bouchard
Journal:  Circ Res       Date:  1992-09       Impact factor: 17.367

2.  Endothelin activation of an inwardly rectifying K+ current in atrial cells.

Authors:  D Kim
Journal:  Circ Res       Date:  1991-07       Impact factor: 17.367

3.  Stimulation of cardiac alpha receptors increases Na/K pump current and decreases gK via a pertussis toxin-sensitive pathway.

Authors:  A Shah; I S Cohen; M R Rosen
Journal:  Biophys J       Date:  1988-08       Impact factor: 4.033

Review 4.  Alpha 1-adrenoceptors in myocardium: functional aspects and transmembrane signaling mechanisms.

Authors:  D Fedida; A P Braun; W R Giles
Journal:  Physiol Rev       Date:  1993-04       Impact factor: 37.312

5.  Modulation of ventricular action potential by alpha 1-adrenoceptors and protein kinase C.

Authors:  R T Dirksen; S S Sheu
Journal:  Am J Physiol       Date:  1990-03

6.  Endothelin-A receptor mediates cardiac inhibition by regulating calcium and potassium currents.

Authors:  K Ono; G Tsujimoto; A Sakamoto; K Eto; T Masaki; Y Ozaki; M Satake
Journal:  Nature       Date:  1994-07-28       Impact factor: 49.962

7.  On the mechanism of action of the beta-1 partial agonist denopamine in regulation of myocardial contractility: effects on myocardial alpha adrenoceptors and intracellular Ca++ transients.

Authors:  M Kohi; I Norota; M Takanashi; M Endoh
Journal:  J Pharmacol Exp Ther       Date:  1993-06       Impact factor: 4.030

8.  Different effects of alpha- and beta-adrenergic stimulation on cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes.

Authors:  G Gambassi; H A Spurgeon; E G Lakatta; P S Blank; M C Capogrossi
Journal:  Circ Res       Date:  1992-10       Impact factor: 17.367

9.  Effect of (+)-niguldipine on myocardial alpha 1-adrenoceptors in the rabbit.

Authors:  M Endoh; M Takanashi; I Norota
Journal:  Eur J Pharmacol       Date:  1992-11-17       Impact factor: 4.432

10.  Species-related differences in inotropic effects of angiotensin II in mammalian ventricular muscle: receptors, subtypes and phosphoinositide hydrolysis.

Authors:  A Ishihata; M Endoh
Journal:  Br J Pharmacol       Date:  1995-01       Impact factor: 8.739

View more
  1 in total

Review 1.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.